Skip to Content

93 5513 93 5513 (Carbamazepine Extended-Release 200 mg)

Pill with imprint 93 5513 93 5513 is Green / Gray, Capsule-shape and has been identified as Carbamazepine Extended-Release 200 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Carbamazepine is used in the treatment of trigeminal neuralgia; epilepsy; schizoaffective disorder; bipolar disorder; borderline personality disorder (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 5513 93 5513

Carbamazepine Extended-Release

93 5513 93 5513
200 mg
Green / Gray
Prescription only
Drug Class:
Dibenzazepine anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.